semaglutide hydrogel Diabetes: system for GLP-1 agonists may reduce injection need GLP-1 drug hydrogels could reduce
Description
We ran that analysis as a single K-Dense Web session
Nomination from Covington & Burling LLP on behalf of Novo Nordisk Inc
Research from clinical trials show that patients who used Wegovy (semaglutide approved for weight loss) lost about 15% of their starting body weight in the first 1 to 1.5 years when compared to a placebo
[DOI] [PubMed] [Google Scholar] 59.Kim J, Nam JH
If you need assistance, our Solutions Engineers are just a click away
